Advanced Therapies, LLC and Minaris Regenerative Medicine are now combined!
Get to know the NEW Minaris Advanced Therapies. Learn More

News

Minaris Regenerative Medicine is proud to share current and past news and announcements from its over twenty years of experience. Please see below for our press releases and announcements.

    *This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, fomerly PCT or PCT Cell Therapy Services), apceth Biopharma GmbH, and Hitachi Chemical Co., Ltd. have been renamed Minaris Regenerative Medicine and are part of the Resonac Group.
    March 5, 2025

    Business alliance with Alfresa Holdings

    Yokohama, Japan - March 5, 2025 - Alfresa Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo) and Minaris Regenerative Medicine Co., Ltd. (Headquarters: Yokohama, Kanagawa are pleased to announce the signing of a Memorandum of Understanding (MoU) aimed at collaborating on Cell Therapy Development and Manufacturing for customers with the goal of enabling clinical and commercial manufacturing of ...
    March 5, 2025

    Business alliance with Alfresa Holdings (Japanese)

    Yokohama, Japan - March 5, 2025 - We are pleased to inform you that Minaris Regenerative Medicine Co., Ltd. and Alfresa Holdings Corporation have signed a memorandum of understanding for collaboration. Details in Japanese for local news in Japan. アルフレッサ ホールディングス株式会社（本社：東京都千代田区、代表取締役社長：荒川隆治、コード番号：2784 東証プライム、以下「アルフレッサHD」といいます）とMinaris Regenerative ...
    All Posts

    Subscribe to Our Email Distribution List
    © 2025 Minaris Regenerative Medicine   |  Privacy Policy   |  Imprint